[ad_1] Biocon Ltd on Thursday, April 10, said its subsidiary Biocon Biologics has received the approval of the US Food and Drug Administration for Jobevne, a biosimilar Bevacizumab, for intravenous use. Jobevne is a recombinant humanised monoclonal antibody that is used to treat several types of cancer. It is a biosimilar to the reference product […]
Everhope Oncology to open cancer treatment centers in Delhi, Mumbai; aims to expand to 10 cities with $10 million in seed funding – CNBC TV18
[ad_1] Narayana Health, W Health Ventures, and 2070 Health have joined forces to launch Everhope Oncology, a chain of medical and surgical oncology centres aimed at bringing cancer treatment closer to patients. With $10 million in seed funding, Everhope will set up facilities in Delhi and Mumbai, with plans to expand to 10 cities over […]
AstraZeneca’s blockbuster drug scores major win in bladder cancer – CNBC TV18
[ad_1] AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the blockbuster medicine. In patients with muscle-invasive bladder cancer, Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care, interim analysis of a late-stage trial found. The medicine also […]